Caring Brands, Inc. (CABR) Fair Value 2026

CABR · Drug Manufacturers - Specialty & Generic ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.0 /10

32 fundamental signals · 0 models active

Value Trap Risk

SAFE (10/100)

Quick Summary — As of 2026-08-28, Caring Brands, Inc. (CABR) trades at $1.39. QOC: 6.0/10. Value Trap Risk: 10/100 (SAFE). 0/13 models active.

Key Facts

Ticker
CABR
Price
$1.39
Quality Score
6.0/10
Value Trap Risk
10/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Limited model coverage (0/13) may reduce confidence

What Fair Value Does Each Model Give CABR?

0 Intrinsic Value Models vs. Current Price ($1.39)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Caring Brands, Inc. (CABR) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Caring Brands, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About CABR?

0 of 13 models are currently active for CABR. See which stocks rank higher →

How Does CABR Rank in Drug Manufacturers - Specialty & Generic?

Among 112 Drug Manufacturers - Specialty & Generic stocks, CABR ranks #58 by Quality of Company score. CirclFi's QOC score of 6.0/10 evaluates 32 fundamental signals. A score of 6.0 reflects mixed fundamentals.

See all Most Undervalued Drug Manufacturers - Specialty & Generic Stocks →

The Drug Manufacturers - Specialty & Generic sector introduces analytical considerations specific to healthcare company businesses. For Caring Brands, Inc., metrics like clinical trial success rate provide important context that general-purpose valuation models may underweight.

Is CABR a Value Trap?

CirclFi's Value Trap algorithm assigns CABR a score of 10/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Caring Brands, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Caring Brands, Inc. scores 6.0 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CABR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Caring Brands, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Drug Manufacturers - Specialty & Generic Stocks Should You Also Analyze?

10 related Drug Manufacturers - Specialty & Generic stocks with 13-model coverage

VTRSViatris Inc.QOC 6.0AQSTAquestive Therapeutics, Inc.QOC 6.0OGIOrganigram Global Inc.QOC 6.1TLRYTilray Brands, Inc.QOC 5.9AAWHAscend Wellness Holdings, Inc.QOC 6.1LFCRLifecore Biomedical, Inc.QOC 5.9PLNHPlanet 13 Holdings Inc.QOC 4.7AMPHAmphastar Pharmaceuticals, Inc.QOC 9.4EBSEmergent BioSolutions Inc.QOC 7.1UTHRUnited Therapeutics CorporationQOC 9.6

Read investment analysis: VTRS · AQST · OGI · TLRY · AAWH · LFCR · PLNH · AMPH · EBS · UTHR

Which Other Stocks Have a Similar Quality Score to CABR?

7 companies across all industries closest to CABR’s Quality of Company score of 6.0/10.

AVDAmerican Vanguard CorporationQOC 6.0NAMIJinxin Technology Holding CompanyQOC 6.0DVLTDatavault AI Inc.QOC 6.0DGXXDigi Power X Inc.QOC 6.0PSFEPaysafe LimitedQOC 6.0CAICaris Life Sciences, Inc.QOC 6.0NVDANVIDIA CorporationQOC 10.0

Read investment analysis: AVD · NAMI · DVLT · DGXX · PSFE · CAI · NVDA

Where Does CABR Sit in CirclFi's Drug Manufacturers - Specialty & Generic Rankings?

CABR is ranked against every other Drug Manufacturers - Specialty & Generic stock CirclFi covers in each of these screens.

See all Drug Manufacturers - Specialty & Generic stocks ranked →

What Else Do Investors Ask About Caring Brands, Inc.’s Valuation?

What is Caring Brands, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Caring Brands, Inc. (CABR). The Quality of Company score is 6.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CABR overvalued or undervalued right now?

At $1.39, 0 of 0 active models suggest CABR may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Caring Brands, Inc.'s business model in Drug Manufacturers - Specialty & Generic.

What does a Quality of Company score of 6.0 mean for CABR?

Caring Brands, Inc.'s QOC of 6.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on CABR?

CirclFi analyzes CABR with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is CABR a value trap in 2026?

Caring Brands, Inc.'s Value Trap score is 10/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Caring Brands, Inc. (CABR) a Quality of Company score of 6.0/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/CABR/ · Methodology
Primary sources for this CABR valuation
  • Financial statements: Caring Brands, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0002020737) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CABR as of ; valuations recomputed .